Swiss All Share Index
16.669,46
PKT
+61,82
PKT
+0,37
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.11.12 | Barry Callebaut hold | Vontobel Research | |
| 08.11.12 | Novartis reduce | Vontobel Research | |
| 08.11.12 | Swiss Re buy | Vontobel Research | |
| 08.11.12 | Swiss Re neutral | Sarasin Research | |
| 08.11.12 | Holcim hold | Vontobel Research | |
| 08.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 07.11.12 | UBS halten | Hamburger Sparkasse AG (Haspa) | |
| 07.11.12 | Sonova equal-weight | Morgan Stanley | |
| 07.11.12 | Barry Callebaut hold | Vontobel Research | |
| 07.11.12 | Novartis reduce | Vontobel Research | |
| 07.11.12 | Adecco SA buy | Vontobel Research | |
| 07.11.12 | Holcim neutral | Sarasin Research | |
| 07.11.12 | Barry Callebaut neutral | Sarasin Research | |
| 07.11.12 | Schindler hold | Vontobel Research | |
| 07.11.12 | Holcim hold | Vontobel Research | |
| 07.11.12 | Adecco SA outperform | Exane-BNP Paribas SA | |
| 07.11.12 | Adecco SA neutral | J.P. Morgan Cazenove | |
| 07.11.12 | UBS buy | Vontobel Research | |
| 06.11.12 | Avolta (ex Dufry) outperform | Exane-BNP Paribas SA | |
| 06.11.12 | Avolta (ex Dufry) neutral | UBS AG | |
| 06.11.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 06.11.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 06.11.12 | Avolta (ex Dufry) underperform | Cheuvreux SA | |
| 06.11.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 06.11.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 06.11.12 | Partners Group buy | Sarasin Research | |
| 06.11.12 | Adecco SA buy | Sarasin Research | |
| 06.11.12 | Adecco SA buy | Vontobel Research | |
| 05.11.12 | Swiss Re sell | Goldman Sachs Group Inc. | |
| 05.11.12 | Novartis neutral | Citigroup Corp. | |
| 05.11.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 05.11.12 | Partners Group hold | Vontobel Research | |
| 05.11.12 | Partners Group neutral | Sarasin Research | |
| 05.11.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 05.11.12 | Avolta (ex Dufry) neutral | Sarasin Research | |
| 05.11.12 | UBS buy | Citigroup Corp. | |
| 06.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 02.11.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 02.11.12 | UBS buy | Société Générale Group S.A. (SG) |